Concerted regulation of wild-type p53 nuclear accumulation and activation by S100B and calcium-dependent protein kinase C

Molecular and Cellular Biology

Volumn 19, Issue 10, 1999, Pages 7168-7180

  Scotto, Christian ^a   Delphin, Christian ^a   Deloulme, Jean Christophe ^a   Baudier, Jacques ^a,b  

^a CEA GRENOBLE   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; PROTEIN KINASE C; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE G1 PHASE; CELLULAR DISTRIBUTION; FIBROBLAST; GROWTH INHIBITION; IRRADIATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION;

MURINAE;

EID: 0032862991     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.10.7168     Document Type: Article

References (67)

1. Aloni-Grinstein, R., D. Schwartz, and V. Rotter. 1995. Accumulation of wt p53 protein upon γ-irradiation induces a G2 arrest-dependent immunoglobulin κ light chain gene expression. EMBO J. 14:1392-1401.
2. Bates, S., and K. Vousden. 1996. p53 in signalling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev. 6:12-19.
3. 2+ binding on S100B protein. J. Biol. Chem. 261:8192-8203.
4. Baudier J., C. Delphin, D. Grunwald, S. Khoshbin, and J. J. Lawrence. 1992. Characterization of the tumor suppressor protein p53 as a protein kinase C substrate and a S100B-binding protein. Proc. Natl. Acad. Sci. USA 89:11627-11631.
5. Baudier, J., E. Bergeret, N. Bertacchi, H. Weintraub, J. Gagnon, and J. Garin. 1995. Interactions of myogenic bHLH transcription factors with calcium-binding calmodulin and S100a (αα) proteins. Biochemistry 34:7834-7846.
6. Beham, A., M. C. Marin, A. Fernandez, J. Herrmann, S. Brisbay, A. M. Tari, G. Lopez-Berestein, G. Lozano, M. Sarkiss, and T. J. McDonnell. 1997. Bcl-2 inhibits p53 nuclear import following DNA damage. Oncogene 15:2767-2772.
7. Blagosklonny, M. V. 1997. Loss of function and p53 protein stabilization. Oncogene 15:1889-1893.
8. Caelles, C., A. Heimberg, and M. Karim. 1994. p53 dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 370: 220-224.
9. De la Monte, S. M., Y. K. Sohn, N. Ganju, and J. R. Wands. 1998. p53- and CD95-associated apoptosis in neurodegenerative diseases. Lab. Investig. 78: 401-411.
10. Deloulme, J. C., M. Sensenbrenner, and J. Baudier. 1990. Interactions of S100 proteins with protein kinase substrates, biological implication, p. 153-157. In R. Pochet, E. M. Lawson, and K. Heizmann (ed.), Calcium binding proteins in normal and transformed cells. Plenum Press, New York, N.Y.
11. Delphin, C., and J. Baudier. 1994. The protein kinase C activator, phorbol ester, cooperates with the wt p53 species of ras-transformed embryo fibroblasts growth arrest. J. Biol. Chem. 269:29579-29587.
12. Delphin, C., K. P. Huang, C. Scotto, A. Chapel, M. Vincon, E. Chambaz, J. Garin, and J. Baudier. 1997. The in vitro phosphorylation of p53 by calcium-dependent protein kinase C. Characterization of a protein kinase C-binding site on p53. Eur. J. Biochem. 245:684-692.
13. Delphin, C., M. Ronjat, J. C. Deloulme, G. Garin, L. Debussche, Y. Higashimoto, K. Sakaguchi, and J. Baudier. 1999. Calcium-dependent interaction of S100B with the C-terminal domain of the tumour suppressor p53. J. Biol. Chem. 274:10539-10544.
14. Di Leonardo, A., S. P. Linke, K. Clarkin, and G. M. Wahl. 1994. DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 8:2540-2551.
15. Dutta, A., S. M. Ruppert, J. C. Aster, and E. Winchester. 1993. Inhibition of DNA replication factor RPA by p53. Nature 365:79-82.
16. El-Deiry, W. S., S. E. Kern, J. A. Pietenpol, K. W. Kinzler, and B. Vogelstein. 1992. Definition of a consensus binding site for p53. Nat. Genet. 1:45-49.
17. Fiscella, M., H. L. Zhang, S. Fan, K. Sakaguchi, S. Shen, W. E. Mercer, G. F. Vande Woude, P. M. O'Connor, and E. Appella. 1997. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 94:6048-6053.
18. Frey, M. R., M. L. Saxon, X. Zhao, A. Rollins, S. S. Evan, and J. D. Black. 1997. Protein kinase C isozyme-mediated cell cycle arrest involves induction of p21waf1/cip1 and p27kipl and hypophosphorylation of the retinoblastoma protein in intestinal epithelial cells. J. Biol. Chem. 272:9424-9435.
19. Gannon, J. V., and D. P. Lane. 1991. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 349:802-805.
20. 1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:6264-6277.
21. Griffin, W. S. T., J. G. Sheng, and R. E. Mrak. 1998. Senescence-accelerated overexpression of S100b in brain of SAMP6 mice. Neurobiol. Aging 19:71-76.
22. Hocevar, B. A., and A. P. Fields. 1991. Selective translocation of βII-protein kinase C to the nucleus of human promyelocytic (HL60) leukemia cells. J. Biol. Chem. 266:28-33.
23. Hermann, J. 1997. The potential for isoenzyme-selective modulation of protein kinase C. FASEB J. 650:649-669.
24. Karnell, R., E. Von Schoultz, L. O. Hansson, B. Nilsson, K. Arstrand, and B. Kagedal. 1997. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyndole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma. Melanoma Res. 7:393-399.
25. Kernohan, N. M., and R. Rankin. 1987. S100 protein: a prognostic indicator in cutaneous malignant melanoma? Histopathology 11:1285-1293.
26. Kitamura, Y., S. Shimohama, W. Kamoshima, Y. Matsuoka, Y. Nomura, and T. Taniguchi. 1997. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 232:418-421.
27. Ko, L. J., and C. Prive. 1996. p53: puzzle and paradigm. Genes Dev. 10: 1054-1072.
28. Kraft, A. S., J. B. Smith, and R. L. Berkow. 1986. Bryostatin, an activator of the calcium phospholipid-dependent protein kinase, blocks phorbol esterinduced differentiation of human promyelocytic leukemia cells HL-60. Proc. Natl. Acad. Sci. USA 83:1334-1338.
29. Kubbutat, M. H., R. L. Ludwig, M. Ashcroft, and K. Vousden. 1998. Regulation of Mdm2-directed degradation by C terminus of p53. Mol. Cell. Biol. 18:5690-5698.
30. Kuo, T. H., H.-R. C. Kim, L. Zhu, H.-M. Lin, and W. Tsang. 1998. Modulation of endoplasmic reticulum calcium pump by Bcl2. Oncogene 17:1903-1910.
31. Lam, M., G. Dubyak, L. Chen, G. Nunez, R. L. Miesfeld, and C. W. Distelhorst. 1994. Evidence that bcl-2 represses apoptosis by regulating endoplasmic reticulum-associated Ca2+ fluxes. Proc. Natl. Acad. Sci. USA 91:6569-6573.
32. Lane, D. P. 1992. p53, guardian of the genome. Nature 358:15-16.
33. Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331.
34. Liang, S. H., D. Hong, and M. F. Clarke. 1998. Cooperation of a single lysine mutation and a C-terminal domain in the cytoplasmic sequestration of the p53 protein. J. Biol. Chem. 273:19817-19821.
35. Linke, S. P., M. P. Harris, S. E. Neugebauer, K. C. Clarkin, H. P. Shepard, D. C. Maneval, and G. M. Wahl. 1997. P53-mediated accumulation of hypophosphorylated pRb after the G1 restriction point fails to halt cell cycle progression. Oncogene 15:337-345.
36. Lucas, M., and V. Sanchez-Margalet. 1995. Protein kinase C involvement in apoptosis. Gen. Pharmacol. 26:881-887.
37. Martinez, J., I. Georgoff, J. Martinez, and A. J. Levine. 1991. Cellular localization and cell cycle regulation by a temperature-sensitive p53 protein. Genes Dev. 5:151-159.
38. Martiny-Baron, G., M. G. Kazanietz, H. Mischak, P. M. Blumberg, G. Kochs, H. Hug, M. Dieter, and C. Schachtele. 1993. Selective inhibition of protein kinase isozymes by the indolocarbazole GÖ6976. J. Biol. Chem. 268:9194-9197.
39. McConkey, D. J., and S. Orrenius. 1994. Signal transduction pathways to apoptosis. Trends Cell Biol. 4:370-375.
40. Michalovitz, D., O. Halevy, and M. Oren. 1990. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671-680.
41. Millward, T. A., C. W. Heizmann, B. W. Schäfer, and B. A. Hemmings. 1998. Calcium regulation of Ndr protein kinase mediated by S100 calcium-binding proteins. EMBO J. 17:5913-5922.
42. Morii, K., R. Tanaka, Y. Takahashi, and R. Kuwano. 1992. Cloning of cDNA encoding human S100 a and b subunits and their differential expression in human tumor cell lines. J. Neurosci. Res. 32:27-33.
43. Nakajima, T., S. Watanabe, Y. Sato, T. Kameya, T. Hirota, and Y. Shimosato. 1982. An immunoperoxidase study of S100 protein distribution in normal and neoplastic tissues. Am. J. Surg. Pathol. 6:715-727.
44. Nishizuka, Y. 1992. Intracellular signalling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607-614.
45. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9:484-496.
46. Polyak, K., T. Waldman, T. C. He, K. Kinzler, and B. Vogelstein. 1996. Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev. 10:1945-1952.
47. Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389:300-305.
48. Ryan, J. J., E. Prochownik, C. A. Gottlieb, I. J. Apel, R. Merino, G. Nunez, and M. Clarke. 1994. c-myc and bcl-2 modulate p53 function by altering p53 subcellular trafficking during the cell cycle. Proc. Natl. Acad. Sci. USA 9:5878-5882.
49. Ryan, K. M-, and K. H. Vousden. 1998. Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest. Mol. Cell. Biol. 18:3692-3698.
50. Sabapathy, K., M. Klemm, R. Jaenisch, and E. F. Wagner. 1997. Regulation of ES cell differentiation by functional and conformational modulation of p53. EMBO J. 16:6217-6229.
51. Schneider, S. A., K. Fukuyama, J. Maceira, and W. L. Epstein. 1985. Effect of ultraviolet B radiation on S100 protein antigen in epidermal Langerhans cells. J. Investig. Dermatol. 84:146-148.
52. Scotto, C., J. C. Deloulme, D. Rousseau, E. Chambaz, and J. Baudier. 1998. Calcium and S100B regulation of p53-dependent cell growth arrest and apoptosis. Mol. Cell. Biol. 18:4272-4281.
53. Serrano, M., A. W. Lin, M. E. McCurrach, D. Beach, and S. W. Lowe. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593-602.
54. Sheng, J. G., R. E. Mrak, and W. S. T. Griffin. 1994. S100b protein expression in Alzheimer's disease: potential role in the pathogenesis of neuritic plaques. J. Neurosci. Res. 39:398-404.
55. Sherbet, G. V., and M. S. Lakshmi. 1998. S100A4 (MTS1) calcium binding protein in cancer growth, invasion and metastasis. Anticancer Res. 18:2415-2422.
56. Smith, M. L., and A. J. Fornace. 1997. p53-mediated protective responses to UV irradiation. Proc. Natl. Acad. Sci. USA 94:12255-12257.
57. Szallasi, Z., C. B. Smith, G. R. Pettit, and P. M. Blumberg. 1994. Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J. Biol. Chem. 269:2118-2124.
58. Tan, M., C. W. Heizmann, K. Guan, B. W. Schafer, and Y. Sun. 1999. Transcriptional activation of the human S100A2 promoter by wild-type p53. FEBS Lett. 445:265-268.
59. Tronnier, M., U. Missler, K. Grotrian, and N. Kock. 1998. Does ultraviolet radiation exposure influence S100b protein plasma level? Br. J. Dermatol. 138:1098-1100.
60. Tsoporis, J. N., A. Marks, H. J. Kahn, J. Butany, P. P. Liu, D. O'Hanlon, and T. G. Parker. 1997. S100β inhibits α1-adrenergic induction of the hypertrophic phenotype in cardiac myocytes. J. Biol. Chem. 272:31915-31921.
61. Utrera, R., L. Collavin, D. Lazarevic, D. Delia, and C. Schneider. 1998. A novel p53-inducible gene coding for a microtubule-localized protein with G2-phase-specific expression. EMBO J. 17:5015-5025.
62. Waga, S., G. J. Hannon, D. Beach, and B. Stillman. 1994. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature 369:574-578.
63. Wang, E., A. N. Murphy, D. E. Bredesen, G. Cortopassi, and G. Fiskum. 1996. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. USA 93:9893-9898.
64. Whitaker-Amitia P., M. Wingate, A. Borella, R. Gerlai, J. Roder, and E. Azmitia. 1997. Transgenic mice overexpressing the neurotrophic factor S100b show neuronal cytoskeletal and behavioral signs of altered aging processes: implication for Alzheimer's disease and Down's syndrome. Brain Res. 776:51-60.
65. Yahanda, A. M., J. M. Bruner, L. A. Donehower, and R. S. Morrison. 1995. Astrocytes derived from p53-deficient mice provide a multistep in vitro model for development of malignant gliomas. Mol. Cell. Biol. 15:4249-4259.
66. Zezula, J., V. Sexl, C. Hutter, A. Karel, W. Schutz, and M. Freissmuth. 1997. The cyclin-dependent kinase inhibitor p21cip1 mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells. J. Biol. Chem. 272:29967-29974.
67. Zhao, X., J. E. Gschwend, T. Powell, R. G. Foster, K. C. Day, and M. L. Day. 1997. Retinoblastoma protein-dependent growth signal conflict and caspase activity are required for protein kinase C-signaled apoptosis of prostate epithelial cells. J. Biol. Chem. 272:22751-22757.